Search Results for keywords:"regulatory guidelines"

The Food and Drug Administration (FDA) has submitted a proposed information collection to the Office of Management and Budget for review under the Paperwork Reduction Act. This collection involves the De Novo classification process, which evaluates if a medical device can be classified as class I or II, assuring its safety and effectiveness in the absence of a similar marketed device. The process includes regulatory guidelines and electronic submission templates. Feedback on the proposal is welcomed until January 29, 2025, via the OMB's online portal.

In a notice from the Federal Energy Regulatory Commission, certain staff members of the Office of Enforcement are declared "non-decisional," which means they cannot advise the Commission or participate in settlement reviews. This designation follows an order dated December 16, 2024, and is mandated by regulatory guidelines. However, there are specific staff exceptions who remain decisional, including members like Nicholas Stavlas and Michael Raibman. This notice is an administrative step to ensure clear roles within the Commission for handling deliberations.

The Office of Justice Programs (OJP), which is part of the Department of Justice, has decided to withdraw a proposed rule from February 5, 2024. This rule aimed to replace the existing Victim Compensation Program Guidelines and update requirements under the Victims of Crime Act. OJP made this decision after receiving a large number of comments and recognizing that more time is needed to consider the feedback properly. For now, the current guidelines remain in place, and OJP may explore a new rule in the future based on further discussions with stakeholders.